QuanDx
San Jose, US · Founded 2012 · California corporation
QuanDx develops molecular diagnostic kits for detecting fusion genes in hematologic malignancies including leukemia, designed to reduce time and cost compared to traditional methods like FISH and RT-PCR. The company serves clinical and research laboratories performing leukemia diagnosis and prognosis assessment.
Founders & leadership
XL
Xiaojun LeiExecutive
Board
GY
Guoliang YuBoard director
CL
Chunlin LiangBoard director
PC
Peng ChengBoard director
Reported raises · per SEC filings
Form D private placements$4M disclosed across 2 rounds · 2013–2015
▶$3MraisedDec 2015 · 11 investors · BiotechnologyRule 506(b)
▶$3MraisedDec 2015 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chunlin LiangDirector
- Guoliang YuDirector
- Peng ChengDirector
- Xiaojun LeiExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Nov 2015
- Incorporated
- Corporation, California, 2012
- Federal exemptions
- 06b
▶$950KraisedJan 2014 · 10 investors · BiotechnologyRule 506(b)
▶$950KraisedJan 2014 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Guoliang YuDirector
- Xiaojun LeiExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $950K
- First sale
- Dec 2013
- Incorporated
- Corporation, California, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does QuanDx do?
- QuanDx develops molecular diagnostic kits for detecting fusion genes in hematologic malignancies including leukemia, designed to reduce time and cost compared to traditional methods like FISH and RT-PCR. The company serves clinical and research laboratories performing leukemia diagnosis and prognosis assessment.
- How much funding has QuanDx raised?
- QuanDx has disclosed $4M raised across 2 rounds.
- Where is QuanDx headquartered?
- QuanDx is headquartered in San Jose, US.